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ABSTRACT 
The history of cell culture dates back to 1907 when Ross Harrison discovered that 
neuronal cells could be cultured in vitro.  Two types of cells used within cell culture include 
primary and established cell lines.  Among established cells HEK 293 and 293T cells are among 
the most widely used in the technique of cell culture.  Lymphatic endothelial cells (LECs) are 
often represented as primary cells, which have been isolated from tissues.  Previous studies have 
characterized 293 and 293T cells as neuronal in origin although phenotypic analyses have not 
been reported. Similarly, studies dealing with the binding characteristics of HIV have revealed 
the expression of podoplanin, a typical LEC marker, by 293T cells.   Additionally, our lab has 
observed the expression of podoplanin by 293 cells through flow cytometry analysis.  These 
observations of podoplanin expression suggest that the phenotype of 293 and 293T cells needs to 
be further explored and that they might resemble LECs.  This study outlines the comprehensive 
mRNA and protein analysis of 293 and 293T cells in the context of LECs using standard and 
real-time RT-PCR and flow cytometry analysis.  Furthermore, this study evaluates the influence 
of culture conditions on LEC marker expression by 293 and 293T cells in an attempt to find 
optimal LEC growth conditions for these cell lines.  Evaluation of mRNA expression levels 
revealed that 293 and 293T cells express multiple LEC markers including Prox-1, Lyve-1, 
PDPN, and VEGFR-3.  Studies investigating the manipulation of culture conditions revealed that 
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293 and 293T cells do not significantly change in LEC marker expression.  Taken together, these 
studies suggest that 293 and 293T cells phenotypically resemble LECs and should be defined as 
LEC-like.   Defining 293 and 293T cells as LECs is highly relevant to the field of public health 
as it provides a new model by which to study LEC function in several different contexts 
including vaccine interaction and cancer metastasis.  
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1.0  INTRODUCTION 
1.1 EARLY HISTORY OF CELL CULTURE 
Though the human body functions as a system comprised of tissues, the isolation of 
specific cells from tissues has provided the ability to understand specific cellular functions.  Cell 
culture is one method by which researchers can investigate the properties of cells.  The first cell 
culture experiment was performed in 1907 when Ross Harrison documented nerve growth [1]. 
Since 1907, cell culture has provided insight into the study of specific cellular function and 
understanding of the body as a whole.  Cells grown in culture can be classified as either 
“primary” or “established”.  The distinct difference between primary and established cells is the 
modification of established cells to continually divide [2].  Through the years, the study of cell 
culture has been developed to include methods to manipulate and differentiate cells using 
supplemented cell culture media, such as growth factors [3].  Similarly, the field of cell culture 
has continued to develop and more recently scientists have been modifying culture conditions 
from a two-dimensional to a three-dimensional level.  The advantage of three-dimensional 
growth is that it better replicates the interaction between neighboring cells and between cells and 
their host environment.  Depending on the area of research, different cell types might be 
preferred.  For example, when studying cellular response to vaccine treatment the results would 
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more likely mimic host response if primary cells were used.  However, many cells within the 
body are not easily maintained and thus, must be modeled using established cell lines.  
1.1.1 Primary cells 
Primary cells are typically isolated from tissue samples that are taken from an individual 
or animal and have a limited life span.  Tissue samples often contain a variety of cell types and 
must be sorted after isolation based on cell size, granularity, or specific cellular markers [3].  
Once cells are isolated from tissue, they are passaged in culture vessels containing supplemented 
media to allow further differentiation.  Unfortunately, some cell lines are difficult to culture and 
therefore have a limit to their research potential due to lack of known cellular markers, limit on 
passage number, or longevity of cellular marker expression.  
1.1.2 Established cells 
Similar to primary cells, established cells are often isolated from tissue for the purpose of 
cell culture.  Once in culture, the cells are manipulated by transformation of tumor or viral genes 
that allow for continuous cellular division [2].  A drawback to the use of established cells is the 
unknown change in phenotype after manipulation.  However, this does not limit their use in 
research, for example; established cell lines can still be used in various areas of research 
including cystic fibrosis and cancer research [4].  A common established cell line used in 
numerous areas of research is the human embryonic kidney (HEK) cell line first isolated by 
Franklin Graham in the 1970s [5].   
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1.2 HUMAN EMBRYONIC KIDNEY CELLS 
1.2.1 The History of HEK293 cells 
The history of human embryonic kidney (HEK) cells dates back to the 1970s when the 
method of transducing cells with DNA was first devised.  Among the first cells to be infected 
with human virus, Adenovirus type 5, were human embryonic kidney cells [5].  Post infection 
these cells were referred to as HEK293 or 293 cells and have since been used for many types of 
research within the scientific community.  Not even 20 years after the origin of 293 cells came 
the origin of 293T cells, the result of transducing 293 cells with a segment of simian virus 40 
containing the large-T antigen [6].  The addition of the SV40 large T antigen into the 293 
genome provided cells with the ability to replicate vectors containing the SV40 origin of 
replication [7].  293 and 293T cells have been used in various areas of study including 
expression of recombinant proteins and vaccine development for Hepatitis E virus [8, 9].  
Despite their frequent use, 293 and 293T cells have not been well characterized.  A limited 
number of studies have been performed in an attempt to determine the origin of 293 cells, 
resulting in the classification of 293 and 293T as neuronal or epithelial in origin [5, 10].  A 
thorough characterization of this cell line could provide insight into interpreting previously 
published data and might open up additional avenues for use of 293 cells.  
1.2.2 Previous Characterization and Use of the HEK293 Cell Line 
Though 293 and 293T cells have not been thoroughly characterized, they have been used 
in many areas of research.  Research using 293 cells has revealed a previously unknown insulin 
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receptor substrate, IRS-4, which undergoes phosphorylation when in the presence of insulin [11].  
Similarly, virology studies have shown novel cytopathic effects in 293 cells infected with 
Hantavirus, a virus that does not normally produce cytopathic effects in mammalian cells [12].  
Previous research has shown the expression of several related neuronal proteins by 293 cells.  
Shaw et al. investigated 293 cells for the expression of neurofilament, a typical neuronal marker, 
and the impact transformation with human adenovirus had on 293 cells [10].  The results 
revealed that 293 cells expressed both the major neurofilament protein and neurofilament light 
chain protein, atypical expression for an isolated kidney cell.  They offered two interpretations of 
their findings: that adenovirus has a rare ability to turn on neurofilament genes not normally 
expressed, or that 293 cells were neuronal in origin [10].  Furthermore, they suggested that 293 
cells do not resemble normal kidney cells and should not be used in kidney related research [10].  
This study investigates the phenotype of 293 and 293T cells in an attempt to better understand 
their use and suggest that they might be lymphatic endothelial cells. 
1.3 THE LYMPHATIC SYSTEM 
One function of the human lymphatic system is to maintain fluid balance within the body.  
The major cell type within the lymphatic endothelium is lymphatic endothelial cells (LECs), 
which make up the subcapsular, cortical, and medullary sinuses of the lymph node [13].  
Lymphatic vasculature is found in most vascularized tissue within the body, with the brain being 
one exception [14].  The lymphatic vascular system was first discovered in the 17th century but 
remained understudied for many years due to a lack of known cellular markers [15].  However, 
an early established function of the lymphatic endothelium is to serve as a conduit to traffic DCs 
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from tissues to the draining lymph nodes during infection [14].  The functions of the lymphatic 
system have been more recently uncovered due to the discovery of lymphatic endothelial cell 
markers Prox-1, PDPN, Lyve-1, and VEGFR-3 which when used in conjunction, aid in pure 
isolation of LECs [15].  
1.3.1 Lymphatic Endothelial Cell Function 
The role lymphatic endothelial cells play within the immune system continues to be 
discovered.  LECs have a unique physical structure where neighboring cells do not overlap and 
are attached to the membrane through fine elastic fibers [16].  This physical property is most 
likely due to the function of the cells to maintain fluid balance between the lymphatic and blood 
vascular system [16, 17].  Known functions of LECs include production of chemokines, such as 
CCL21, to attract mature dendritic cells expressing CCR7 to the draining lymph node [18].  
More recently, reports have suggested that LECs might play a more significant role in detection 
and presentation of antigen through the expression of antiviral factors and toll like receptors [19, 
20].  Similarly, LECs have been shown to express D6, a receptor that is able to remove 
chemokines such as CCL21, from the environment.  This function helps LECs regulate 
trafficking of DCs during local inflammation [21]. 
1.3.2 Lymphatic Endothelial Cell Marker Expression 
Lymphatic endothelial cells express multiple markers that allow for a more definitive 
characterization and differentiation.  Five commonly used markers to distinguish LECs include 
Prox-1, PDPN, VEGFR-3, CCL21 and Lyve-1.  The recent discovery of these markers has 
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allowed for a better understanding of LECs and the lymphatic vasculature as a whole [14].  LEC 
phenotype, like many other cell lines, is defined by the expression of multiple cellular markers.  
This is particularly true for LECs because some markers expressed by LECs are also expressed 
by other cell types [16].  For example, Lyve-1 is expressed in LECs and is often used to separate 
primary LECs from blood endothelial cells (BECs), but can also be found in liver and spleen 
sinusoidal tissue [16].  Similarly, VEGFR-3 is frequently used in conjunction with another LEC 
marker to distinguish LECs, but can be expressed by BECs albeit to lower levels [22].  Though 
LECs maintain their phenotype when cultured for a minimal number of passages, the method of 
isolation (use of Lyve-1 or VEGFR-3 and PDPN) might determine the cellular marker 
expression profile of the cultured cells post isolation [16].  These five markers play distinct roles 
in LEC phenotype and since each of its discovery have been used to isolate and characterize 
LECs.  
1.3.2.1 Prox-1 
Prospero-related homeobox gene-1 (Prox-1) is a nuclear protein that functions as a 
transcriptional regulator for LEC marker expression [23, 24].  At approximately day nine of 
developing mouse embryos, a specific subset of blood endothelial cells begins expressing Prox-
1.  These Prox-1 expressing cells are among the first to emerge from the cardinal vein and begin 
the lymphatic vasculature and to further differentiate into LECs [25].  Studies have shown Prox-
1 knock-out mice are deficient in lymphatic vasculature and that IL-3 might regulate the 
presence of Prox-1 on LECs [23, 26].  Prox-1 expression also functions as the major factor 
determining differentiation between BECs and LECs, with expression conferring an LEC 
phenotype [13].  
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1.3.2.2 Podoplanin 
Podoplanin (PDPN) is a cell surface transmembrane protein that is expressed on a variety 
of cell types from LECs to kidney cells.  PDPN expression is regulated depending on the cellular 
environment.  For example, LECs upregulate PDPN through expression of LEC marker, Prox-1 
[24].  However, there must be other mechanisms for regulation of PDPN other than Prox-1 due 
to the fact that fibroblasts express PDPN, but not Prox-1 [24].  Similar to the unknown regulation 
is the relatively unknown function of PDPN.  It was recently demonstrated that on LECs PDPN 
functions in the trafficking of DCs to the lymph node and plays a role in wound healing and 
migration of cells [24].  PDPN has also been shown to bind both CLEC-2, normally expressed on 
DCs, and CCL21, a chemokine expressed by LECs both of which help direct DCs to the lymph 
node [24].  
1.3.2.3 VEGFR-3 
Another cellular marker expressed by LECs is vascular endothelial growth factor three 
(VEGFR-3).  In addition to Prox-1, VEGFR-3 expression on LECs causes them to sprout from 
the cardinal vein and differentiate into LECs [13].  Furthermore, mice deficient in VEGFR-3 lack 
many of the lymphatic vessels and often die around day 15 [13].  Previous research has shown 
that though Prox-1 is needed for LEC differentiation and formation of vasculature, signaling via 
VEGF-C, the ligand for VEGFR-3, is needed for lymphatic sprouting [13].  The signaling 
cascade driven by VEGFR-3 is still being uncovered, but to date it is understood that VEGFR-3 
induces the PI3-K pathway and eventually the Akt and mitogen-activated protein (MAP) kinase 
pathway [13].  VEGFR-3 has five tyrosyl phosphorylation sites along the carboxyl terminal tail, 
one of which specifically binds Shc and GRB2, which activate the RAS signaling pathway [27].   
 8 
1.3.2.4 Lyve-1 
Lymphatic endothelial hyaluronan (HA) receptor, Lyve-1, was first discovered by 
searching for HA receptors similar to CD44, which is the HA receptor expressed on BECs [28].  
Lyve-1 and CD44 share approximately 43% similarity, with the majority of homology 
comprising the HA binding region [29].  Studies also confirmed that Lyve-1 was expressed by 
endothelial cells through staining of human umbilical vein endothelial cells (HUVECs) and by 
co-expression of other LEC markers [30].  Lyve-1 has been shown to bind HA although the 
functional significance of binding to HA within the lymphatics is still being investigated [28].  
Two possible hypotheses exist for LEC expression of Lyve-1.  First, Lyve-1 might act as a 
transporter for HA, which would then be processed by LECs.  Alternatively it might play a 
structural role in which it helps with the passage of cells through the endothelium [28].   
1.3.2.5 CCL21 
CCL21 is a chemokine that is typically produced by LEC to aid in the movement of DCs 
to the draining lymph nodes.  The CCL21 receptor, CCR7 is expressed by DCs that have come 
into contact with antigen and been successfully activated [31].  In the presence of inflammation, 
LECs have been reported to up-regulate CCL21 production [21].  Other reports suggest that DC 
migration patterns are determined by type of inflammatory stimulation, but overall movement is 
primarily dependent on LEC production of CCL21 [31].  Along with up-regulation during 
inflammation, CCL21 production might be determined in part by expression of another cellular 
marker, CD137 [32].  CD137 is known for its activation properties among T cells and NK cells 
and is a member of the TNF-α superfamily, which in turn, can signal through the NF-κB 
pathway [32].  Reports have shown that LECs co-express Lyve-1 or PDPN with CD137 post 
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inflammation and that expression of CD137 on LECs causes an increase in CCL21 production 
[32]. 
1.4 DETERMINANTS OF CELL CHARACTERIZATION 
Within basic research, cell culture remains one of the most widely used methods to model 
in vivo responses with one of the main challenges being reproducibility between cellular 
responses in vitro and cellular responses in vivo.  Choosing an appropriate cell line to model the 
human system is one way in which investigators can maximize reproducibility.  Ideally, the 
chosen primary cell or cell line would be fully characterized and well explored.  However, many 
cell lines have not been fully characterized and this limitation could affect our understanding of 
the results when unsuitable cells are used.  For instance, HeLa cells were recently observed to 
differ from normal human cells on multiple levels after DNA and RNA deep sequencing [33].  In 
fact, it is reported that misidentified cell lines are becoming increasingly public and that actions 
should be pursued to eliminate misleading results [34].   
According to the FDA for the production of biological products for licensure, cell lines 
should be characterized based on several criteria including, but not limited to, the history of the 
cell line, including species of isolation and culture methods, characteristics of the cell line 
including expression of specific markers, and how much the cell line resembles other cultures of 
the same cell line [35].  Though slightly different in application, these standards should also be 
taken into consideration in the field of basic research.  Defining the expression of specific 
markers is of particular importance when evaluating cells or cell lines that do not have a strongly 
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defined function, making evaluation of mRNA and protein expression a significant part of cell 
line characterization.  
1.5 SUMMARY 
Cell culture plays an important role within the field of research and development from 
being involved in initial experiments on vaccine potency to discovery of specific cellular 
function within the human body.  Primary cells and established cell lines are the two cell states 
used in cell culture differing in their potential to continuously divide.  HEK293, also known as 
293 cells, are an example of an established line that is able to undergo continuous division due to 
transformation by human adenovirus 5 DNA [5].  In contrast, primary cells, which do not have 
the potential for continuous division, are isolated from host tissues.  LECs are an example of 
primary cell populations that are typically isolated from tissues using markers such as Lyve-1, 
PDPN, Prox-1, and VEGFR-3.  LECs differ from blood endothelial cells (BECs) through 
expression of other specific markers and through their function, trafficking DCs and 
lymphocytes to the lymph node and maintaining fluid homeostasis between the blood and 
lymphatic systems [16].  Investigations into the phenotype of 293 cells have been minimal and 
previous results have revealed the expression of neurofilament proteins, leading others to 
propose they are neuronal [10].  Despite this highly limited phenotypic characterization of 293 
cells, they remain one of the most widely used cell types for cell culture. 
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2.0  STATEMENT OF THE PROBLEM 
Until the discovery of lymphatic endothelial cell markers, isolation and study of LECs 
was difficult [14].  LECs still remain a somewhat understudied cell population due to the recent 
identification of specific LEC markers: Prox-1, VEGFR-3, Lyve-1, and PDPN.  Similarly, 293 
and 293T cells have not been thoroughly studied on their surface markers and do not have a 
defined phenotype.  However, recent studies by Chaipan et al. using 293T cells to investigate 
HIV binding strategies revealed that an HIV attachment factor, CLEC-2, could bind and 
incorporate into virus particles the cellular receptor PDPN, a LEC marker expressed by 293T 
cells [36].  The expression of PDPN by 293T cells, though not the primary focus of their study, 
provided an initial suggestion that HEK293 and 293T cells might have some connection to cells 
of the lymphatic lineage.  Similarly, our lab has observed the expression of PDPN on 293 cells 
intended for use as a negative control for flow cytometric staining of LECs (Berendam, 
unpublished data).  The revelation that 293 cells express an LEC marker, PDPN, raised the 
question as to whether they might express multiple LEC markers, and to what extent they 
resemble LECs.  If 293 cells do express LEC markers and arguably can be re-characterized as 
LEC-like, they might be sued as model LECs.  The objective of these studies was to 
investigate the extent to which 293 and 293T cells resemble LECs and to explore their 
LEC-likeness through alternative culture conditions.   
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2.1 SPECIFIC AIM 1: DETERMINE THE PHENOTYPIC RESEMBLANCE 
BETWEEN HEK293, HEK293T CELLS AND LECS 
LECs play an integral role in the lymphatic endothelium and are characterized by their 
expression of cellular markers including: PDPN, Prox-1, Lyve-1, VEGFR-3, and CCL21.  Each 
of the cellular markers provides structural and functional properties and their presence and levels 
of expression are one determinant of LEC-likeness.  Cellular marker expression by 293 and 293T 
has not been thoroughly studied and is necessary to determine the phenotype of these cells.  The 
observed expression of PDPN by 293 and 293T cells reveals a possible new phenotype based on 
LEC marker expression.  293 and 293T cells must exhibit expression of multiple LEC markers to 
be considered LEC-like. Furthermore, characterization of 293 and 293T cells, as LEC-like is 
dependent on the level of expression of LEC markers relative to a known control.  Standard RT-
PCR was performed to determine the expression of some LEC markers by 293 and 293T cells.  
Real-time RT-PCR was used to quantify expression of a large set of additional markers, both 
LEC markers and LEC-associated markers, relative to a known endogenous control, beta-
glucuronidase (GUSB).  To determine if the protein expression of 293T cells was similar to 
LECs flow cytometry staining was performed for PDPN and Lyve-1.  Real-time RT-PCR 
expression levels revealed that 293 and 293T cells express multiple LEC markers to similar 
levels as human dermal LECs (HDLECs).  Similarly, flow cytometry staining revealed that 293T 
cells exhibit protein expression concordant with observed mRNA levels.    
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2.2 SPECIFIC AIM II: DETERMINE THE LEC-LIKE POTENTIAL OF HEK293 
AND 293T CELLS USING CULTURE MANIPULATION 
Cells grown in cell culture can be influenced by supplemented factors within the growth 
medium [3, 37].  Primary LECs are often cultured in the presence of VEGF-C, one of the two 
ligands of VEGFR-3 [16, 38].  Since the presence of VEGFR-3 has been associated with LEC 
attachment and sprouting from the cardinal vein, VEGF-C has been proposed as being essential 
for the growth of LECs in cell culture conditions [38].  Similarly, manipulation of culture 
conditions by transforming cells or growing in three-dimensional environments can induce 
changes in cellular marker expression and differentiation [39, 40].  As previously discussed, 
another factor that determines the LEC phenotype is the transcriptional regulator, Prox-1 and 
forced expression of this protein might result in up-regulation of LEC marker mRNA expression 
levels [23, 24].  Three-dimensional culture of cells has become a recent model that better reflects 
the in vivo environment [41].  It represents the in vivo environment by providing more realistic 
cell-cell contact and cell-environment contact [40].  One factor influencing the study of 293 and 
293T cells grown in three-dimensional culture is that previous studies have reported that 293 
cells have the potential to de-differentiate when grown in low attachment environments [40].  
This de-differentiation might provide an ability to re-differentiate 293 cells further into LECs, 
which eventually could serve as an LEC cell line.  Additionally, since 293 and 293T cells are 
LEC-like, they might up-regulate LEC markers when grown in three-dimensional culture, similar 
to human umbilical vein endothelial cells (HUVECs) previously grown in three-dimensional 
culture using fibrin matrices [42].  
To further investigate 293 and 293T LEC-like potential and resemblance, cells were 
grown in a variety of manipulated culture conditions including: VEGF-C treatment, transfection 
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with a plasmid expressing Prox-1, and seeding cells into three-dimensional culture conditions.  
Results revealed that 293 and 293T cells do not up-regulate cellular marker expression similar to 
LECs, as previously shown, in response to VEGF-C [37].  Transfection studies reveal that over 
expression of Prox-1 in 293 cells might significantly impact Prox-1 and Lyve-1 mRNA 
expression but in 293T cells does not significantly change LEC marker mRNA expression.  
Results from three-dimensional culture studies also revealed little to no change in differentiation 
and up-regulation of LEC markers by 293 and 293T cells using either a hanging drop method or 
low attachment method [39, 40].   
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3.0  MATERIALS AND METHODS 
3.1 CELL CULTURE CONDITIONS 
HEK293 (ATCC CRL-1573) and HEK293T (ATCC CRL-11268, Michele Calos, 
Stanford Registry no. S97-079) cells were maintained in DMEM (Fisher, cat no. BW12-614F) 
supplemented with 5% fetal bovine serum (Hyclone), 1X penicillin/streptomycin (Invitrogen, 
15140163) at a final concentration of 2000U/500mL media, and 1X L-glutamine (Life 
Technologies) with a final concentration of 2mM.  Table 1 shows culture conditions for each of 
the cell lines used.  Cells were split every 2-3 days or when 70% confluency was reached by 
treating with 0.025% for 293T cells or 0.05% for more adherent cells, 293, Tzm-bl, and Caco-2, 
trypsin (Fisher).  Cells were then resuspended in media containing FBS to stop trypsin action and 
aliquoted into 15 mL conical tubes.  Tubes were pelleted for 5 minutes at 1200 rpm and then 
resuspended in fresh media and seeded into T25 or T75 culture flasks.  Established cell lines 
were grown to a maximum of approximately 30 passages. 
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Table 1.  Cell Lines and Culture Media. 
 
3.2 ISOLATION OF RNA 
To dissociate cells, 900µL of Trizol reagent (Invitrogen) was added to cell monolayer or 
pellet and incubated for five minutes at room temperature.  Cell lysates were then treated with 
chloroform, isopropanol, and ethanol for purification.  Cell pellets were also treated to remove 
contaminating genomic DNA with DNase I (Ambion) and then eluted using RNeasy mini kit 
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(Qiagen).  RLT and RPE buffers were prepared for use by adding 10µL of beta-mercaptoethanol 
to every 1mL RLT buffer used and adding 44mL 96%-100% ETOH to buffer RPE (RNeasy mini 
kit protocol).  RNA was washed by mixing 250µL 96%-100% ETOH and 350µL RLT buffer and 
eluted using columns included in RNeasy mini kit.  Columns were washed two times with buffer 
RPE and RNA was eluted in a final volume of 20-30µL nuclease free water.  Final RNA 
concentration was measured using a NanoPhotometer (Implen, version 2.1).   
3.3 cDNA SYNTHESIS FOR STANDARD RT-PCR 
cDNA for standard RT-PCR was prepared by mixing 2µg of total RNA with 2µL Oligo 
dT (from Promega RT kit) and adjusted to 5µL with the addition of NFW.  Samples were placed 
into Peltier Thermal Cycler model PTC-200 from MJ Research at 70°C for 5 minutes and then 
immediately placed on ice for 5 minutes.  RT mixture was set up according to Table 2 for one 
sample.  A volume of 5µL of prepared RNA was added to 15µL of RT mixture.  Reactions were 
placed in the Peltier Thermal Cycler from MJ Research and run according to the following 
conditions: 
25°C for 5 minutes 
43°C for 1 hour 
70°C for 15 minutes 
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Table 2.  cDNA Synthesis Reaction Setup for Standard RT-PCR. 
 
3.4 STANDARD RT-PCR 
Standard RT-PCR was performed using previously designed primers or newly designed 
primers as listed in Table 3.  Primers were designed by aligning human sequences obtained from 
the GenBank sequence repository for the target marker using the Vector NTI program.  Table 4 
outlines the volume and mass of reagents combined for one reaction.  To prepare cDNA, 2.0µg 
of RNA was added to each reaction mixture.  To perform standard RT-PCR, 2.5µL of cDNA was 
added to each reaction tube.  3-5µL of PCR product was run using 0.5X TBE buffer on a 1% 
agarose gel against a 1Kb plus ladder (Invitrogen).  PCR conditions were as follows using a 
Peltier Thermal Cycler model PTC-200 from MJ Research. 
 
94°C for 3 minutes 
94° C for 30 seconds 
68°C for 30 seconds 
72°C for 2 minutes 
72°C for 10 minutes 
4°C for forever 
35 cycles 
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Table 3.  Primer Sequences for Standard RT-PCR. 
 
 
 
Table 4.  Standard RT-PCR Master Mix Setup. 
 
3.5 cDNA SYNTHESIS FOR REAL-TIME RT-PCR 
cDNA was prepared for real-time RT-PCR using 5µL of 80ng/µL purified RNA, for a 
total of 400ng RNA per reaction tube.  No reverse transcription (NRT) tubes served as a negative 
control by lacking RT SSII (Invitrogen).  Both RT and NRT reaction mixtures are included in 
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Table 5. Amplification was performed in Peltier Thermal Cycler model PTC-200 from MJ 
Research using the following conditions: 
25°C for 10 minutes 
48°C for 30 minutes 
95°C for 5 minutes 
4°C for forever 
 
Table 5.  cDNA Master Mix Setup for Real-Time RT-PCR. 
 
3.6 REAL-TIME RT-PCR 
  Real-time RT-PCR was performed using commercially available Taqman primer and 
probe sets (Table 6) or by SYBR green detection assay (WT1 and Synaptopodin) (Table 7).  
Previously designed primers for macaque sequences were aligned with human WT1 and 
Synaptopodin from NCBI to determine if primer regions were in consensus [43].  Primers were 
modified due to single nucleotide differences between human and macaque sequences and 
purchased through IDT website for SYBR Green detection (Life Technologies) (Table 7). 
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Table 6.  Real-time Taqman Assays Purchased from Life Technologies. 
 
Table 7.  Primer Sequences for SYBR Green Assays.  
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3.7 FLOW CYTOMETRY STAINING 
Cells were removed from culture dish using 0.025% trypsin for five minutes at RT and 
trypsin action was stopped using media containing FBS and spun down at 1200rpm for 5 minutes 
at RT.  Cells were counted using a haemocytometer and resuspended to a total number of cells 
based on cell density.  DNAse I (Roche) was added to the total number of cells (200,000 cells 
per sample) to obtain a final concentration of 0.1mg/mL and were incubated for 30 minutes at 
37°C, 5% CO2.  Cells were washed with 1XPBS, resuspended, and stained using Live-Dead 
Aqua Stain (Life Technologies) for 30 minutes at RT covered from light using aluminum foil.  
Cells were resuspended in 20µL of azide-free blocking buffer (Innovex) and stained using anti-
human podoplanin-PE (Angibio, cat no. 11-009PE), anti-human lyve-1-APC (R&D Systems, cat 
no. FAB20892A), Rat IgG2a-PE (BD Biosciences cat no. 555844) as a matched isotype control 
to anti-human podoplanin-PE, or Mouse IgG1-APC (BD Biosciences cat no. 555751) as a 
matched isotype control to anti-human lyve-1-APC.  Cells were stained for one hour at 4ºC then 
washed with 1X PBS and resuspended in blocking buffer/paraformaldehyde for a final 
concentration of 0.25% PFA and acquired using BD Fortessa (access kindly granted by Dr. 
Rinaldo and the MACS) using the PE yellow/green channel for detection of cells stained 
positively for anti-human podoplanin and APC channel for detection of cells stained positively 
for anti-human lyve-1.  
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3.8 VEGF-C TREATMENT OF 293 AND 293T CELLS 
293 and 293T cells were seeded at a density of 8,000 cells/cm2 in a T25 flask with 
complete DMEM and incubated overnight at 37˚C, 5% CO2 to allow cell attachment.  At 24 
hours post-plating, medium was supplemented with 0.2µg/mL VEGF-C (Acro-biosystems) at 
37˚C, 5% CO2, for 48 hours.  Cells were then washed twice with 1X PBS (without calcium and 
magnesium) and prepared for RNA extraction (above) using 900µL Trizol reagent. RNA was 
purified including DNAse I treatment (Ambion) and RNeasy column purification (Qiagen) and 
analyzed using real-time RT-PCR (Taqman primer/probe set for Apolipoprotein L2).  
3.9 3-D HANGING DROP MODEL FOR CELL CULTURE 
Spheroids were formed using the hanging drop model by plating 500 cells in either 25µL 
or 50µL onto non-adherent square petri dishes (Greiner Bio-One) in a 20% methylcellulose 
(Sigma-Aldrich cat no. M0512) supplemented DMEM medium, as previously described [39].  
Methylcellulose media was made by measuring 0.6g methylcellulose and placing into a bottle 
able to be autoclaved with a sterile stir bar and autoclaving.  Warm 50mL complete media to 60 
ºC and after autoclaving methylcellulose, add 25mL warmed media under sterile conditions to 
bottle and place on stir plate (medium speed) for 20 minutes at RT.  Add 25mL warmed media to 
jar under sterile conditions and placed on stir plate overnight at 4 ºC.  Aliquot 25mL media into 
two 50mL conical tubes and spin in centrifuge for 3 hours, 3500g, at 4 ºC [39].  Cells were 
incubated upside down overnight at 37ºC and 5% CO2.  Spheroids grown for seven days were 
formed and maintained in culture with sterile water in the bottom of the plate to maintain 
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hydration of methylcellulose drops.  Spheroids were washed from square petri dishes using 1X 
PBS without calcium and magnesium to harvest spheroids.  Spheroids were allowed to settle for 
30 minutes by gravity sedimentation in a 50mL conical tube and then all liquid was removed 
above the spheroids.  For extraction of RNA, 900µL of Trizol was then added to the spheroids 
and pipette up and down and allowed to sit for 5 minutes then stored at -80°C until time of 
extraction.  To form a spheroid plug, 50µL of 4% paraformaldehyde (in 1X PBS) was added to 
the spheroids and incubated on ice for 15 minutes and then at RT for 15 minutes.  
Paraformaldehyde/PBS was carefully removed and replaced with 50µL of a 0.33% agarose/PBS 
solution stored at 37ºC and placed on ice for 15 minutes to solidify.  After the plug had solidified 
it was placed in 10% sucrose/PBS followed by 20% sucrose/PBS each for 4 hours and then 
frozen using methylbutane stored on dry ice for 45 minutes to reach a temperature of -65ºC.  
Frozen plugs were stored at -80°C and allowed to thaw at -20°C for 2 hours prior to 
cryosectioning.  Spheroid plugs were cut into 10µm cryosections and placed on glass slides 
(SuperFrost Plus, Fisher).  Glass slides containing sections were immediately placed on a 60°C 
warm plate for 20 minutes before being stored at -80°C.  Slides were allowed to sit at room 
temperature and then placed in paraformaldehyde for 5 minutes then stained for hematoxylin and 
eosin by being dipped in hematoxylin for 2 minutes followed by a single dip in eosin.  Slides 
were washed twice with Millipore water and then washed with 70%, 80%, and 95% ETOH for 5 
minutes each followed by xylenes for 5 minutes before being cover slipped using Permount 
(Fisher Scientific). 
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3.10 3-D LOW ATTACHMENT METHOD 
Cells were cultured in low-attachment conditions as previously described [40].  Low-
attachment dishes were prepared by dissolving 13.4g of DMEM high glucose powder (GIBCO) 
in 3.7g of sodium bicarbonate solution (Life Technologies) then filtered in sterile conditions 
using a 0.22 micron filter.  Prior to use, media was pre-warmed at 37°C.  Agarose solution was 
made by mixing 1.0g standard agarose (Invitrogen) into 100mL deionized water and boiling in 
microwave between 30 seconds and 1 minute to dissolve.  Lastly, equal parts of agarose solution 
and warmed DMEM were used to coat cell culture dish to a thickness of approximately 4mm.  
For this protocol, G-10 Agarose (Biowest) was replaced with standard agarose.  293T or 293 
cells were seeded at a density of 3x106 onto 60mm petri dishes and incubated at 5%CO2, 37ºC 
for six or seven days, respectively.  Spheroids were collected and spun down at 1200rpm for 5 
minutes at room temperature then gently re-suspended in PBS and centrifugued again to remove 
any excess agarose within the media.  Spheroids were analyzed for change in Nanog, Nestin, or 
LEC marker mRNA expression using real-time RT-PCR (Table 6).   
3.11 OVEREXPRESSION OF PROX-1 VIA TRANSFECTION 
Transfections were completed by plating 500,000 or 1 million cells in 12-well or 6-well, 
respectively, on to tissue culture treated plates.  Plates were coated with a 1:5 dilution of poly-L-
lysine to ensure attachment of cells to culture dish.  Poly-L-lysine solution was made by 
reconstituting 3.0mg of poly-L lysine in 30mL sterile water under sterile conditions. The solution 
was then filtered using a 0.22 micron filter and working stock was created by diluting 1:5 in 
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nuclease free water.  Plates were coated with 1:5 dilution by adding enough poly-L lysine that it 
covers the well.  The solution was allowed to sit for 10 minutes with swirling of the plate every 
few minutes to ensure coverage.  The mixture was then pulled off and washed with 1X PBS and 
set to dry for 2 hours before plating cells.  Cells were seeded at a density of 500,000 cells in 1 
mL or 1x106 cells in 2mL onto 12-well or 6-well plates, respectively, and allowed to incubate at 
37ºC overnight or until cells reach 70-80% confluency before beginning the transfection.  
Complete medium was changed to a volume of 0.5mL 30-60 minutes prior to addition of the 
Polyjet (Signa Gen)/DNA reagent mixture.  For a 12-well plate, DNA was diluted to 0.403µg 
and suspended in 20.16µL of serum-free medium for each well.  Similarly, 1.21µL Polyjet 
reagent was mixed into 20.16µL for each well to form a DNA to Polyjet ratio of 1:3.  Diluted 
Polyjet reagent was added to diluted DNA and incubated for 15 minutes at room temperature to 
allow the DNA and Polyjet to form a complex.  DNA/Polyjet mixture was then added dropwise 
to each well and incubated for 12 hours.  Transfection efficiency was checked by visualizing 
GFP transfected wells using a FITC cube at approximately at 48 hours post-transfection for 
harvesting of cells.  RNA was isolated from lysates as described above and analyzed for changes 
in LEC marker expression.  Plasmids used included empty vector pcDNA3.1, pcDNA3.1rhesus-
Prox-1, and pcDNA3.1human-Prox-1, the latter expressing the rhesus macaque and human Prox-
1 cDNAs, respectively (generated by Stella Berendam). 
3.12 STATISTICAL ANALYSIS 
Statistical analysis for repeated studies (VEGF-C treatment, Prox-1 transfections, and 
three-dimensional culture of spheroids) was performed using GraphPad Prism version 6. A 
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student’s paired t-test was performed to determine significance of data at a 0.05 level.  Spearman 
correlation analysis was performed using the 2-∆Ct values for the multiple genes and cell lines and 
performed using GraphPad Prism version 6.   
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4.0  RESULTS 
To date, there is no cell line that can appropriately model LECs.  Given that 293 cells 
have been previously shown to express PDPN, a LEC marker, analysis of their phenotype might 
reveal their potential to be defined as LEC-like and provide a model cell line for LECs.  To 
explore further LEC marker expression by 293 and 293T cells standard and real-time RT-PCR 
were performed.  Flow cytometry staining was used to validate protein expression by 293T cells 
and several attempts were made to deepen the LEC-like phenotype of 293 and 293T cells 
through manipulation of culture conditions using treatment with VEGF-C, transfection with a 
plasmid containing Prox-1, and placement into three dimensional culture.  The results revealed a 
strong LEC-like phenotype for 293 and 293T cells and suggested that these cells should be re-
defined as LEC-like. 
4.1 STANDARD RT-PCR REVEALS HEK293 AND 293T CELLS EXPRESS 
MULTIPLE LEC MARKERS 
To confirm expression of PDPN and to evaluate expression of other LEC markers by 293 
and 293T cells, cDNA was prepared using RNA from cell lysates. Human dermal lymphatic 
endothelial cells (HDLEC) served as a positive control population with no reverse transcriptase 
(NRT) tubes serving as negative controls. Primers were previously designed or newly designed 
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using published human sequences for each specific marker, based on sequences in GenBank, 
choosing an area of approximately 50% G-C content and avoiding areas that will fold back and 
self-align. Primers were evaluated and purchased using the IDT website.   
Standard RT-PCR using PDPN-specific primers revealed that 293 and 293T cells express 
PDPN mRNA as do HDLEC, with NRT controls being clean (Figure 1).  These results are 
concordant with previously observed data within our lab and from previous study using 293 and 
293T cells (Berendam, unpublished data) [36].  To validate further the uniqueness of expression 
of PDPN by 293 and 293T cells using standard RT-PCR, three additional cell lines were 
obtained.  The three human cell lines included were: Caco-2, intestinal epithelial cells; A549, 
airway epithelial cells; and 786-O, kidney epithelial cells.  Standard RT-PCR results showed that 
PDPN expression was not unique to 293 and 293T cells when compared to three other epithelial 
lines, but expression appears to be higher among 293 and 293T cells than other epithelial cell 
lines (Figure 2).  To investigate mRNA expression of other LEC markers, standard RT-PCR was 
also performed using specific primers for VEGFR-3, Lyve-1, and Prox-1, on six cell types 
(Figures 3-5).  CD31, also known as PECAM-1, a typical endothelial cell marker, was also 
investigated for mRNA expression among the six cell lines, using primers designed for standard 
RT-PCR (Figure 6).  Lastly, to evaluate the presence of an endogenous expression of beta-
glucuronidase (GUSB), standard RT-PCR was performed on the six cell lines previously 
analyzed (Figure 7).  Six additional cell lines were included in standard RT-PCR analysis for 
GUSB that will be included in real-time RT-PCR analysis (Figure 12).   
 
 30 
 
Figure 1.  PDPN mRNA expression by 293 and 293T cells Revealed Through Standard RT-PCR.  
Results confirm PDPN mRNA expression by 293 and 293T cells using human dermal lymphatic 
endothelial cells (HDLEC) as positive control. RT indicates samples where reverse transcriptase was added and 
NRT refer to control samples in which reverse transcriptase was not added.  Shifted bands might be due to a splice 
variation within the PDPN mRNA sequence.  Expected band size = 560bp 
 
 
Figure 2.  PDPN mRNA Expression by Six Cell Lines Revealed Through Standard RT-PCR. 
Results confirm PDPN mRNA expression by 293 and 293T cells using human dermal lymphatic 
endothelial cells (HDLEC) as positive control. RT indicates samples where reverse transcriptase was added and 
NRT refer to control samples in which reverse transcriptase was not added.  Caco-2, A549, and 786-O are epithelial 
cells included to determine uniqueness of PDPN mRNA expression.  Shifted bands might be due to a splice 
variation within the PDPN mRNA sequence.  Expected band size = 560bp 
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Figure 3.  VEGFR-3 mRNA Expression by Six Cell Lines Revealed Through Standard RT-PCR.   
Results confirm VEGFR-3 mRNA expression by 293 and 293T cells using human dermal lymphatic 
endothelial cells (HDLEC) as positive control.  RT indicates samples where reverse transcriptase was added and 
NRT refer to control samples in which reverse transcriptase was not added.  Caco-2, A549, and 786-O are epithelial 
cells included to determine uniqueness of VEGFR-3 mRNA expression.  Expected band size = 550bp 
 
 
Figure 4.  Prox-1 mRNA Expression by Six Cell Lines Revealed Through Standard RT-PCR. 
Results confirm Prox-1 mRNA expression by 293 and 293T cells using human dermal lymphatic 
endothelial cells (HDLEC) as positive control.  RT indicates samples where reverse transcriptase was added and 
NRT refer to control samples in which reverse transcriptase was not added.  Caco-2, A549, and 786-O are epithelial 
cells included to determine uniqueness of Prox-1 mRNA expression.  Expected band size = 550bp 
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Figure 5.  Lyve-1 mRNA Expression by Six Cell Lines Revealed Through Standard RT-PCR. 
Results confirm Lyve-1 mRNA expression by 293 and 293T cells using human dermal lymphatic 
endothelial cells (HDLEC) as positive control.  RT indicates samples where reverse transcriptase was added and 
NRT refer to control samples in which reverse transcriptase was not added.  Caco-2, A549, and 786-O are epithelial 
cells included to determine uniqueness of Lyve-1 mRNA expression. Expected band size = 530bp 
 
 
Figure 6.  CD31 mRNA Expression by Six Cell Lines Revealed Through Standard RT-PCR. 
Results confirm CD31 mRNA expression by 293 and 293T cells using human dermal lymphatic 
endothelial cells (HDLEC) as positive control.  RT indicates samples where reverse transcriptase was 
added and NRT refer to control samples in which reverse transcriptase was not added.  Caco-2, A549, and 
786-O are epithelial cells included to determine uniqueness of CD31 mRNA expression.  Expected band 
size = 650 bp 
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Figure 7.  GUSB mRNA Expression by Six Cell Lines Revealed Through Standard RT-PCR. 
Results confirm GUSB mRNA expression by 293 and 293T cells using human dermal lymphatic 
endothelial cells (HDLEC) as positive control.  RT indicates samples where reverse transcriptase was added and 
NRT refer to control samples in which reverse transcriptase was not added.  Caco-2, A549, and 786-O are epithelial 
cells included to determine uniqueness of GUSB mRNA expression.  Expected band size = 576 bp 
 
Overall, standard RT-PCR confirmed previous findings that 293 and 293T cells express 
PDPN, a known LEC marker (Berendam, unpublished data) [36].  Standard RT-PCR also 
revealed that 293 and 293T cells express two other LEC markers, VEGFR-3 and Prox-1.  
However, this expression was not observed using primers designed for Lyve-1 or CD31, a 
common endothelial cell marker.  Lastly, standard RT-PCR showed that mRNA expression of 
LEC markers is not unique to 293 or 293T cells because the included epithelial cell lines, Caco-
2, A549, and 786-O, also expressed several of the LEC markers.  Though standard RT-PCR also 
revealed relatively equal levels of GUSB expression, quantitative measurement of mRNA 
expression levels would more accurately show the comparative level of expression and allow for 
a more thorough interpretation of overall LEC marker expression. 
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4.2 REAL-TIME RT-PCR REVEALED THE COMPARATIVE LEVELS OF LEC 
MARKER EXPRESSION BETWEEN 293, 293T CELLS, HDLECS, AND OTHER CELL 
LINES 
Standard RT-PCR confirmed LEC marker mRNA expression by 293 and 293T cells but 
further analysis using real-time RT-PCR was performed to measure relative expression levels. 
Secondly, to better understand the mRNA expression levels in 293 and 293T cells, six additional 
cell lines were added to the study including epithelial cells, lymphocytes, and pre-monocytic 
cells.  The cell lines, tissue origin, host disease state, and cell type as described by American 
Type Culture Collection (ATCC) are listed in Table 8.  In conjunction with incorporation of 
multiple cell types, it was necessary to evaluate the appropriateness of different endogenous 
controls, beta-glucuronidase (GUSB) and Rpl13a, for use in comparing the different cell types. 
Figure 8 shows the amplification plots and mean, median, range, and standard deviation values 
calculated using Ct values from the cell populations for GUSB and Rpl13a.  These analyses 
revealed that GUSB had a smaller range and standard deviation than Rpl13a, with a difference of 
0.2 in standard deviation and 0.88 in range (Figure 8b).  This difference indicates that GUSB is a 
more suitable endogenous control for use across multiple cell lines within this study.  
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Figure 8.  Statistical Analysis of Endogenous Controls, GUSB and Rpl13a. 
Statistical analysis from mRNA expression of endogenous controls using Ct values of 12 different cell 
lines. A) Amplification plots for both GUSB and Rpl13a visibly show a difference in the range of Ct values between 
GUSB and Rpl3a.  B)  Statistical analysis revealed that GUSB had a smaller standard deviation and range than 
Rpl13a, making it a more appropriate endogenous control. 
 
Real-time RT-PCR was performed on RNAs from 293 and 293T cells for LEC marker 
expression using purchased Taqman primers and probes as listed in Table 6.  Along with 
investigating LEC marker mRNA expression, many other cellular markers were included, 
including CD26, Wilm’s tumor 1 (WT1), and Synaptopodin (Synpo).  Podocytes, which are a 
kidney cell type, also express the LEC marker podoplanin, and so to determine if 293 and 293T 
cells resemble kidney podocytes, WT1 and Synpo were included in this initial analysis.  Primers 
for WT1 and Synpo were adapted for human sequences from previously published macaque 
primers and the sequences are listed in Table 7 [43].  CD26, also known as dipeptidylpeptidase 
IV (DPPIV), is an enzymatic marker that can cleave certain oligopeptides, including 
chemokines, and is also expressed by LECs [44].  CD26 was also analyzed for expression by 293 
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and 293T cells to compare the expression levels of LEC-associated markers between 293, 293T, 
and HDLECs.  Two additional LEC-related markers, CCL20 and CD209 were also included to 
compare expression by 293, 293T, and HDLECs.  CCL20 is a chemokine similar to CCL21, 
which is expressed in mucosal surfaces and aids in the trafficking of CCR6 positive cells, often 
DCs, T cells, and B cells, to the lymphatic endothelium [18].  On the other hand, CD209, also 
known as DC-SIGN, is a marker typically expressed by antigen presenting cells (APCs), 
including DCs and macrophages, that aids in cell adhesion and trafficking [45].  Figures 9 and 10 
show mRNA expression levels for LEC markers, podocyte markers, CD26, CCL20, CD31, and 
CD209 by 293 and 293T cells respectively.  Using this approach, I found that 293 and 293T cells 
express four of the five LEC markers, three of which were expressed to levels nearly equivalent 
to GUSB.  Similarly, both 293 and 293T cells expressed WT1, Synpo, CD31 and CD26.  As a 
control population of known LECs, HDLECs were also analyzed for mRNA expression of the 
described genes and results are represented in Figure 12.  Comparing Figures 9, 10, and 11 
reveals that 293 and 293T cells express Prox-1 and VEGFR-3 to similar levels as HDLEC and 
that all three cell populations express podocyte markers WT1 and Synpo.  
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Figure 9.  Real-time RT-PCR results for 293 cells. 
Results reveal 293 cells express LEC markers: PDPN, Lyve-1, Prox-1, CCL21, and VEGFR-3 as well as 
CD26, CD31, CCL20, CD209, and podocyte markers, WT1 and Synaptopodin.  Asterisks designate that CT values 
were not obtained within 50 cycles.  Real-time RT-PCR was run using purchased Taqman primer/probes or SYBR 
green assay detection for WT1 and Synpo. Bars represent 2-ΔCt values calculated using mean Ct values from 
duplicate wells. 
 
 
Figure 10.  Real-time RT-PCR results for 293T cells. 
Results reveal 293T cells express LEC markers: PDPN, Lyve-1, Prox-1, CCL21, and VEGFR-3 as well as 
CD26, CD31, CCL20, CD209, and podocyte markers, WT1 and Synaptopodin.  Asterisks designate that CT values 
were not obtained within 50 cycles.  Real-time RT-PCR was run using purchased Taqman primer/probes or SYBR 
green assay detection for WT1 and Synpo. Bars represent 2-ΔCt values calculated using mean Ct values from 
duplicate wells. 
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Figure 11.  Real-time RT-PCR results for HDLECs. 
Results reveal HDLECs express LEC markers: PDPN, Lyve-1, Prox-1, CCL21, and VEGFR-3 as well as 
CD26, CD31, CCL20, CD209, and podocyte markers, WT1 and Synaptopodin.  Asterisks designate that CT values 
were not obtained within 50 cycles.   Real-time RT-PCR was run using purchased Taqman primer/probes or SYBR 
green assay detection for WT1 and Synpo. Bars represent 2-ΔCt values calculated using mean Ct values from 
duplicate wells. 
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Table 8.  Tissue, Cell Type, and Disease State of Incorporated Cell Lines. 
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Table 9.  Cell Markers, Typical Expression, and Function. 
[2, 10, 13, 18, 23, 24, 26, 44-48] 
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To investigate more fully the mRNA expression profiles of 293 and 293T cells, a total of 
12 cell populations were included in a larger analysis.  Table 8 lists the tissue, disease state, and 
cell type for each of the cell lines included in the mRNA analysis and Table 9 lists the genes 
investigated and example functions.  Real-time RT-PCR was performed and analyzed relative to 
the previously validated endogenous control, GUSB.  Figure 12 is a block diagram representing 
the mRNA expression level for each gene of interest, relative to GUSB expression, for each cell 
population.  Results were concordant with standard RT-PCR results that revealed 293 and 293T 
cells are not the only cell lines to express multiple LEC markers.  However, 293 and 293T cells 
relative level of expression of LEC markers is more similar to HDLEC relative expression levels 
of LEC markers than any other cell type. 
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Figure 12.  Block Diagram Representing mRNA Expression for a Panel of Genes. 
  Cell lines were analyzed using Taqman primer/probes or SYBR Green Assay (WT1 and Synpo). HDLEC 
act as positive control LEC population. Table 8 lists the tissue, disease state, and cell type of each cell line included. 
Reactions were prepared in 96-well plates including duplicate RT wells and single NRT wells.  Each block 
represents the relative expression of each gene to endogenous control, GUSB.  Absence of a block designates that 
CT values were not obtained within 50 cycles.  
 
The genes included in Figure 12 can be grouped into several categories including: LEC 
markers (PDPN, Prox-1, VEGFR-3, Lyve-1, and CCL21), additional markers (CCL20, IL-7, IL-
7R, IL-3, IL-3Ra, SPNS-2), endothelial cell markers (CD40, CD26, and CD31) DC-associated 
markers (CD209 and CD206), and podocyte and neuronal markers (NEFL, WT1, and Synpo).  
Results indicate that all but one cell line expressed at least one LEC marker, indicating that 
expression of one LEC marker is not uncommon.  Similarly, all of the included cell lines 
expressed either WT1 or Synpo, revealing that expression of these markers does not strictly 
indicate a cell line is podocytic and that 293 and 293T cells are not likely to be podocytes despite 
expression of these markers.  Furthermore, 293 and 293T cells express endothelial markers 
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CD40 and CD31, although slightly lower than HDLEC, which again suggests their possible 
LEC-like lineage.  When comparing 293 and 293T cells to one another, real-time analysis 
reveals a slight difference in mRNA expression between the two cell lines including expression 
for CCL20, CD40, and CD209.  A reasonable suggestion for this difference in expression might 
be due to the presence of SV40 T antigen within 293T cells and not 293 cells.  Additionally, the 
lack of expression of CCL21, a known chemokine expressed by LECs, might propose a lack of 
LEC function by 293 and 293T cells, despite the presence of many LEC markers.  However, 
results also suggest that 293 and 293T cells express markers that might have functional 
properties including CD26, an enzymatic marker that can cleave chemokines and spinster 2 
(SPNST-2), a transporter of lipid mediator, sphingosine-1 phosphate, which acts to transport 
lymphocytes during inflammation [44, 49, 50].  Further functional analysis of 293 and 293T cells 
for example, involving chemotaxis assays, would further reveal their functional potential.   
Taken together, these results show the unique levels of mRNA expression by 293 and 
293T cells and their resemblance to HDLEC when comparing LEC markers VEGFR-3, PDPN, 
and Prox-1, suggesting that phenotypically 293 and 293T cells strongly resemble LECs. This 
argument is strengthened by the addition of nine other cell lines of differing origin, which do not 
show unique levels of mRNA expression comparable to HDLECs.  Secondly, real-time RT-PCR 
results reveal that almost all cell types investigated expressed at least one LEC marker, leading to 
the conclusion that expression of one or two markers, even to higher levels, is not a strong 
indicator of LEC origin.  Even more interesting was the common expression of WT1 and Synpo 
among all cell types, suggesting that they are typical markers expressed by cells in culture.  
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4.3 SPEARMAN CORRELATION ANALYSIS REVEALS STRONG 
RELATIONSHIPS BETWEEN LEC MARKER EXPRESSION LEVELS 
The correlation between the expression levels of two markers can help shed light upon 
the relation between those markers and the importance of correlated marker expression.  A non-
parametric Spearman analysis was performed using the 2-∆Ct values to investigate the 
relationships among the expression levels of multiple markers.  These analyses revealed that 
among the markers analyzed the strongest correlations were among LEC markers, VEGFR-3 and 
Prox-1, and PDPN and Lyve-1, with R-values of 0.776 and 0.797, respectively (Table 10, 
Figures 13 and 14).  As R-values approach one, they have a more linear relationship, indicating a 
strong positive correlation.  The opposite is also true as, R-values approach negative one it 
indicates there is a strong negative correlation between expression levels of the two markers 
analyzed.  Furthermore, p-values were analyzed and the relationship between VEGFR-3 and 
Prox-1 revealed a significant p-value of 0.004 and the relationship between PDPN and Lyve-1 
revealed a significant p-value of 0.003 (Table 10).   Figures 13 and 14 represent the relationship 
between LEC markers and revealed that 293 and 293T cells are among the top three cell lines, 
along with the HDLECs expressing high levels of LEC markers.  The significant positive 
relationship between PDPN and Lyve-1 also reveals that cell types can be placed into two 
different groups: a group of cells expressing PDPN and Lyve-1 to low levels and a group of cells 
expressing high levels of PDPN and Lyve-1.  The HDLEC, are among the cells expressing high 
levels of both Lvye-1 and PDPN, suggesting that LEC phenotype is associated with higher levels 
of both PDPN and Lyve-1 expression.  
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Table 10.  Spearman Correlation Analysis R-Values and Associated P-values. 
 
 
Figure 13.  XY Data Plot of Correlation between VEGFR-3 and Prox-1 mRNA Expression. 
Spearman Correlation analysis was performed on 2-∆Ct values of 12 cell lines for VEGFR-3 and Prox-1. 
Analysis revealed a strong positive correlation between VEGFR-3 and Prox-1 with an R -value of 0.776 and a p-
value of 0.004. Blue dot represents HDLEC, red dot represents 293T cells, green dot represents 293 cells, and purple 
dot represents 786-O cells, a cell line which has low mRNA expression of both Prox-1 and VEGFR-3. 
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Figure 14.  XY Data Plot of Correlation between PDPN and Lyve-1 mRNA Expression. 
Spearman Correlation analysis was performed on 2-∆Ct values of 12 cell lines for PDPN and Lyve-1. 
Analysis revealed a strong positive correlation between PDPN and Lyve-1 with an R -value of 0.797 and a p-value 
of 0.003. Blue dot represents HDLEC, red dot represents 293T cells, green dot represents 293 cells, and purple dot 
represents CEM cells which have low levels of PDPN and Lyve-1 mRNA expression.  
 
Furthermore, these results indicate that there might be some mechanisms involved in 
regulation of LEC markers, dependent on other LEC marker expression.  In particular, Prox-1 
mRNA expression has a significant positive correlation with VEGFR-3, PDPN, and Lyve-1 
mRNA expression.  This supports the finding that Prox-1 regulates VEGFR-3 expression 
amongst LECs [51].   Additionally, among all of the genes analyzed, there are only 10 significant 
correlations, with five of them being between LEC markers and only one being a negative 
correlation between IL-3Rα and NEFL.   
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4.4 FLOW CYTOMETRIC ANALYSIS OF LEC MARKERS ON 293T CELLS 
FURTHER CONFIRMS THEIR LEC-LIKENESS 
Results from both standard RT-PCR and real-time RT-PCR, (Figures 1-11) revealed that 
293 and 293T cells expressed multiple LEC markers at the mRNA level to a similar degree as 
HDLECs.  To extend the mRNA analyses, flow cytometric staining was performed to measure 
the protein expression on 293T cells for LEC markers, Lyve-1 and PDPN.  Previous experiments 
have been performed using HDLECs to demonstrate PDPN protein expression using flow 
analysis [26].  PDPN was chosen as an appropriate protein for staining due to its high level of 
mRNA expression by 293T cells (Figure 12), giving an anticipated result of high levels of 
protein staining.  In contrast, Lyve-1 levels were measured by 293T cells leading to an 
anticipated low level of Lyve-1 protein staining.  Figure 15 shows the gating strategy and results 
for both Lyve-1 and PDPN individual staining, as well as Lyve-1/PDPN dual staining.  Given 
that 293T cells are a homotypic population, the gating strategy included gating on the population 
of interest through analyzing the forward and side scatter properties and excluding debris, dead 
cells, and doublets (Figure 15, top panel).  A total of 30,000 cells were acquired for each sample 
and positively stained cells were gated based on staining of an aliquot of cells in parallel with 
isotype-matched controls.   
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Figure 15.  Flow Cytometry Double and Single Staining for PDPN and Lyve-1 Expression by 293T 
cells. 
293T cells were stained were single stained or double stained with Lyve-1 or PDPN antibodies. Gating 
strategy (top panel) is shown using Isotype control, Rat IgG 2a-PE.  293T cells stained for Lyve-1 expression with 
anti-human lyve-1-APC (R&D, cat no. FAB20892A) showed 29.3% positive stain and cells stained for PDPN 
expression with anti-human podoplanin-PE (Angiobio, cat  no. 11-009PE) showed 99.9% positive stain after gating 
on respective Isotype controls. Dual staining for Lyve-1 and PDPN revealed 99% positive PDPN staining and 19% 
positive Lyve-1 staining for 293T cells. 
 
   
Overall 98% of 293T cells stained strongly for PDPN and approximately 20% stained for 
Lyve-1 when cells were stained with individual antibodies (Figure 15).  Double stained cells 
showed that all Lyve-1 positive cells were also PDPN positive, but not all PDPN positive cells 
were Lyve-1 positive (Figure 15).  This is concordant with mRNA expression levels for PDPN 
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and Lyve-1 (Figure 12). These results also reveal that high PDPN mRNA expression is not from 
a small subset of cells, but is consistently expressed throughout the 293T cell population.   
This experiment further reveals the phenotypic resemblance between 293T cells and 
HDLEC through not only mRNA expression, but also through cell surface protein expression. 
Moreover, it confirms that 293T cells consistently express LEC markers Lyve-1 and PDPN at the 
mRNA and protein levels.  
4.5 TREATMENT OF 293 AND 293T CELLS WITH VEGF-C FAILS TO SHOW 
UPREGULATION OF A VEGF-C INDUCED GENE 
Isolated primary LECs are typically cultured in the presence of VEGF-C due to its 
necessity for attachment and survival in culture settings.  As previously stated, VEFG-C is one of 
the two ligands for VEGFR-3, a marker expressed by LECs.  The functional role of VEGF-C for 
LECs has been thoroughly investigated with results pointing to VEGFR-3’s early role as an LEC 
marker and the necessity of VEGF-C for LEC growth, which can be produced in vivo by BECs, 
smooth muscle cells, and mesenchymal cells [52].  Previous studies have explored the impact of 
VEGF-C treatment on LECs through microarray analysis, finding an up-regulation in 
Apolipoprotein L2 (Apol L2), amongst other mRNAs, although Apol L2 was most strongly 
upregulated [37].  Given that 293 and 293T cells express VEGFR-3 and that VEGF-C is a 
necessary supplement for primary cultured LECs, 293 and 293T cells were cultured in the 
presence of VEGF-C to observe if they respond similarly to LECs in their upregulation of Apol 
L2 [37].  Secondly, since VEGFR-3 is an early marker expressed by LECs and LECs are grown 
in the presence of VEGF-C, signaling through VEGFR-3 might impact the expression levels of 
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other LEC markers.  Lastly, since 293 and 293T cells are embryonic in origin, they might exhibit 
some plasticity allowing them to be pushed into a more LEC-like phenotype, as revealed by 
higher mRNA expression of LEC markers in the presence of VEGF-C.  To investigate the impact 
VEGF-C treatment might have on Apol L2 and LEC marker mRNA expression levels, 293 and 
293T cells were seeded at a density of 200,000/25cm2.  Cells were allowed to attach overnight 
and medium was supplemented with a final concentration of 0.2µg/mL recombinant human 
VEGF-C for 48 hours.  Results shown in Figure 16 indicate that there was no significant change 
in mRNA expression levels of Apolipoprotein L2 in the presence of VEGF-C, unlike previous 
findings, which suggest a four-fold change in LEC upregulation of Apol L2 after six hours of 
treatment (Figure 16) [37].  Similarly, there was not a significant change in LEC marker mRNA 
expression after VEGF-C treatment in 293 and 293T cells.  When comparing 293 and 293T cell 
up-regulation of LEC markers, 293 cells show a higher change in both VEGFR-3 and Prox-1 
mRNA expression of approximately 1-fold, compared to relatively no fold change in 293T cell 
mRNA expression, suggesting that 293 cells might have a greater potential to change under 
adverse culture conditions (Figure 17). 
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Figure 16.  Change in Apolipoprotein L2 After Treatment with VEGF-C. 
293 and 293T cells were seeded at a density of 200,000 cells/T25 flask. Cells were allowed to attach 
overnight, then treated with 0.2ug/mL rh-VEGF-C for 48 hours. Student’s paired T-test reveals no significant 
change in Apolipoprotein L2 expression after treatment for 48 hours with VEGF-C by 293 or 293T cells. This figure 
is a representation of two independent experiments where bars represent mean values and points represent individual 
experimental values. 
 
 
Figure 17.  Change in LEC Marker Expression After Treatment with VEGF-C. 
293 and 293T cells were seeded at a density of 200,000 cells/T25 flask. Cells were allowed to attach 
overnight, then treated with 0.2ug/mL rh-VEGF-C for 48 hours. Points represent 2-ΔΔCt value calculated using the 
average Ct value from duplicate wells.  This figure is a representation of two independent experiments where bars 
represent mean values and points represent individual experimental values.  Student’s paired t-test revealed no 
significant change in VEGFR-3 or PDPN mRNA expression after treatment for 48 hours with VEGF-C. 
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 Despite a lack of change in Apol L2 and LEC marker mRNA expression upon treatment 
with VEGF-C, 293 and 293T cells still maintain their expression of LEC markers.  A lack of up-
regulation of Apol L2 in 293 and 293T cells could be explained by continuous culture in the 
absence of VEGF-C and therefore loss of dependence on it, leading to a more defined phenotype 
and signaling pathway than previously thought.  Further studies will be needed to more fully 
determine the reason for a lack of response in 293 and 293T cells following VEGF-C treatment.  
4.6 3D CULTURE SHOWS LITTLE CHANGE IN DE-DIFFERENTIATION 
MARKER EXPRESSION WITH SIMULTANEOUS MAINTENANCE OF LEC 
MARKER EXPRESSION BY 293 AND 293T CELLS 
For many years, two-dimensional cell culture of adherent cells, which includes the 
interaction between cells and a plastic surface on which to attach and grow, was used for in vitro 
study.  More recently, however, three-dimensional (3D) culture has been developed that involves 
interaction between neighboring cells and their environment, more accurately mimicking the in 
vivo environment in which most cells will exist.  Three-dimensional culture of adherent cells in 
environments of low to no attachment causes the formation of spheroids or multi-cellular 
aggregates, which can change cell-cell interactions, cell morphology, and cell matrix interactions 
[40].  One example of how 3D culture can affect cellular marker expression was shown with 
embryonic stem cells and how they maintained their stem phenotype [40].  Other studies have 
shown the ability to differentiate stem cells into LECs through use of treatment with growth 
factors through three dimensional formation of embryoid bodies [44].  Likewise, 293 cells grown 
in three-dimensional culture have the ability to up-regulate stem markers and cell specific 
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differentiation markers [40].  For the purpose of this study, two different methods were 
attempted to form spheroids using 293 and 293T cells to analyze the effects of such culture 
conditions on mRNA expression of stem markers and LEC markers.  De-differentiation of 293 or 
293T cells would provide the opportunity to specifically re-differentiate them using LEC growth 
conditions, such as treatment with VEGF-A and VEGF-C, perhaps resulting in cells that are even 
more LEC-like [44].   
  
4.6.1 Low Attachment Method 
One method used to form spheroids requires the use of low attachment substrates so that 
cells are not able to adhere to the culture plate [40].  This method has been used to study the 
change in stem properties of non-stem cell lines after grown in low attachment conditions.  They 
found that 293 and RT4 cells could form spheroids after 24 hours of incubation using low 
attachment dishes (Figure 18) [40].  Analysis of stem-like properties revealed approximately a 
1,000-fold increase in Nanog expression after five or 10 day incubation of 293 cells.  Similarly, 
they reported a 14-fold change in ectoderm marker, Nestin, by 293 cell aggregates, which 
indicates a de-differentiation of the cell line due to its origin from mesoderm [40].  To further 
investigate if 293 and 293T cells could undergo reprogramming to a de-differentiated state, cells 
were grown in low attachment dishes on agarose for seven or six days, respectively and then 
analyzed using real-time RT-PCR for Nanog and Nestin mRNA expression. Similarly, real-time 
RT-PCR was performed for LEC markers, Lyve-1 and Prox-1 to determine the impact of low 
attachment culture on LEC marker expression.  Results show that spheroid formation using low 
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attachment dishes does not induce an up-regulation of de-differentiation marker expression or a 
change in expression of LEC marker, Prox-1, by 293 or 293T cells (Figures 19 and 20). 
 
Figure 18.  293 Spheroids Formed using Low Attachment Method. 
293 cells were seeded at a density of 3x106 on 66mm petri dishes on high glucose DMEM/agar for 6 days 
to form spheroids. Image was captured using IDEA Spot Camera at 100X. 
 
 
Figure 19.  Change in Stem Markers and Prox-1 mRNA Expression in 293 Spheroids Formed in Low 
Attachment Dishes. 
293 cells were seeded at a density of 3x106 on 66mm petri dishes on high glucose DMEM/agar for 7 days 
to form spheroids. Real-time RT-PCR was performed for stem marker, Nanog, de-differentiation marker, Nestin, 
and LEC markers Prox-1 and Lyve-1 for changes in mRNA expression. Points represent the 2-ΔΔCt value calculated 
from the mean of duplicate wells. Mock Ct values were used for both low attachment analysis and hanging drop 
analysis. Student’s paired T-test revealed no significant difference between mock and low attachment spheroid 
mRNA expression for Nanog, Nestin, or Prox-1.  Lyve-1 Ct values were undetected (CT values above 50) and were 
not included in this analysis. 
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Figure 20.  Change in Stem Markers and Prox-1 mRNA Expression in 293T Spheroids Formed in 
Low Attachment Dishes. 
293T cells were seeded at a density of 3x106 on 66mm petri dishes on high glucose DMEM/agar for 6 days 
to form spheroids. Real-time RT-PCR was performed for stem marker, Nanog, de-differentiation marker, Nestin, 
and LEC markers Prox-1 and Lyve-1 for changes in mRNA expression. Points represent the 2-ΔΔCt value calculated 
from the mean of duplicate wells. Mock Ct values were used for both low attachment analysis and hanging drop 
analysis. Student’s paired T-test revealed no significant difference between mock and low attachment spheroid 
mRNA expression for Nanog, Nestin, or Prox-1.  Lyve-1 Ct values were undetected (CT values above 50) and were 
not included in this analysis. 
 
 
Although, 3D growth of 293 and 293T cells in low attachment conditions showed no 
significant change in stem marker expression, a second approach was pursued to attempt 
replicating previous results [40].   
4.6.2 Culture of 293 and 293T Cells Using The Hanging Drop Method 
One method for forming spheroids in vitro involves the use of methylcellulose and 
gravity to discourage attachment of cells to a culture dish surface.  To form hanging drops 
spheroids, 293 and 293T cells were seeded at a density of 500 cells per 25µL of methylcellulose 
supplemented complete DMEM media for 24 hours on plastic square petri dishes.  Both 293 and 
293T cells formed spheroids after 24 hours, similar to previous studies using HUVECs [39].  To 
investigate spheroid morphology, 293T spheroids were grown for seven days, then fixed, 
processed, sectioned and stained with hematoxylin and eosin (Figure 21).  
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Recent studies have shown the up-regulation of stem marker and de-differentiation 
marker mRNA expression after culture of 293 cells as spheroids for seven days [40].  To 
replicate this study using the hanging drop method, 293 and 293T cells were seeded at a density 
of 500 cells per 25µL and incubated for a total of seven days.  Real-time RT-PCR was performed 
on purified RNAs to investigate changes in mRNA expression levels of Nanog, a stem marker, 
and Nestin, a de-differentiation marker [40].  Similarly, LEC marker expression was investigated 
to determine if 3D culture had an ability to up-regulate expression.  Results showed a slight 
increase in expression of Nanog, with an average of a 3-fold change by 293T spheroids, but 
relatively no change in 293 cells.  A paired student’s T-test revealed no significant change in 
Nanog, Nestin, or Prox-1 expression for 293 and 293T cells.  However, 293 cells revealed 
approximately a 400-fold difference in expression of Nestin in one replicate.  To determine if 
that experiment is an outlier, a third independent experiment would need to be completed and 
statistical tests performed for Nestin mRNA expression by 293 cells. Results reveal that 293T 
cells have a consistent expression of Nestin, and approximately 2-fold change in Prox-1 
expression when cultured in hanging drops (Figures 23 and 24).   
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Figure 21.  293T Hanging Drop Spheroid. 
293T cells were seeded at a density of 500 cells/25 µL DMEM/methylcellulose media and incubated at 
5%CO2, 37ºC, for seven days. Spheroids were cryosectioned and stained with Hematoxylin and Eosin.  
 
 
Figure 22.  Change in Nanog mRNA Expression in Spheroids Formed in Hanging Drops. 
293 and 293T cells were seeded at a density of 500 cells/25 µL DMEM/methylcellulose media and incubated at 
5%CO2, 37ºC, for seven days. Student’s paired T-test revealed no significant change in mRNA expression levels for 
Nanog by 293 or 293T spheroids formed in hanging drop culture. 
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Figure 23. Change in Nestin mRNA Expression in Spheroids Formed in Hanging Drops. 
293 and 293T cells were seeded at a density of 500 cells/25 µL DMEM/methylcellulose media and 
incubated at 5%CO2, 37ºC, for seven days. Student’s paired T-test revealed no significant change in mRNA 
expression levels for Nestin by 293 or 293T spheroids formed in hanging drop culture. 
 
 
 
Figure 24.  Change in Prox-1 mRNA Expression in Spheroids Formed in Hanging Drops. 
293T cells were seeded at a density of 500 cells/25 µL DMEM/methylcellulose media and incubated at 
5%CO2, 37ºC, for seven days.  Student’s paired T-test revealed no significant change in mRNA expression levels for 
Prox-1 by 293 or 293T spheroids formed in hanging drop culture. 
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In an attempt to increase expression of de-differentiation markers and reveal a more 
stem-like phenotype, 293 and 293T cells were grown in two different environments that induce 
spheroid formation.  Results from both the hanging drop method and the low attachment method 
reveal that 293 and 293T cells did not de-differentiate in our hands and that under these 3D 
culture conditions they nevertheless maintained their LEC-like phenotype (Figures 19-24).   
4.7 TRANSFECTION OF A PLASMID CONTAINING PROX-1 REVEALS LITTLE 
CHANGE IN LEC MARKER EXPRESSION 
The function of Prox-1 within the lymphatic endothelium has been investigated in several 
contexts revealing that it is the master regulator of lymphatic differentiation, has the ability to 
guide sprouting and polarity of growth from the cardinal vein, and can induce VEGFR-3 
expression [23, 51, 53].  Given Prox-1’s dynamic function and presence within LECs (Figure 12) 
transfection studies were performed on 293 and 293T cells with a plasmid containing a cDNA 
encoding the Prox-1 open reading frame (ORF) in an attempt to overexpress Prox-1 within 293 
and 293T cells and to create a more LEC-like phenotype.  Cells were seeded onto 12 well plates 
and treated with a Polyjet-plasmid DNA mixture according to the manufacturer’s 
recommendations.  Cells were checked for transfection efficiency using pEGFP-N1 transfected 
wells as a positive control and were analyzed by real-time RT-PCR.  In response to transfection 
with a plasmid expressing Prox-1, 293 and 293T cells did not show a robust change in LEC 
markers VEGFR-3 or Lyve-1 (Figures 25 and 26).  Changes in the levels of Prox-1 signals could 
be due to contaminating, undigested Prox-1 plasmid DNA, despite DNase treatment.  Two forms 
of plasmids containing Prox-1 were used to transfect 293 and 293T cells, including versions 
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expressing the human and rhesus derived ORFs.  Transfected cells were compared to mock 
transfected cells, which received treatment of Polyjet alone and empty vector control, 
pcDNA3.1.  
 
Figure 25.  Change in LEC Marker Expression by 293 Cells Transfected with Prox-1. 
293 cells were seeded into 12 well plates and transfected with plasmids containing rhesus or human Prox-1.  
Transfection of plasmid containing Prox-1 was calibrated to mock transfected wells, which contained Polyet 
reagent, but no DNA.  Empty vector, pcDNA3.1 also served as a negative control. Cells were harvested 48 hours 
post transfection and checked for transfection efficiency using peGFPN1 transfected wells (data not shown).  
Human Prox-1 transfected 293 cells showed a significant upregulation of Prox-1 mRNA expression with a p-value 
of 0.032. Points represent independent experiments and bars represent the mean of two independent experiments. 
 
 
Figure 26.  Change in LEC Marker Expression by 293T Cells Transfected with Prox-1. 
293T cells were seeded into 12 well plates and transfected with plasmids containing rhesus or human Prox-
1.  Transfection of plasmid containing Prox-1 was calibrated to mock transfected wells, which contained Polyet 
reagent, but no DNA.  Empty vector, pcDNA3.1 also served as a negative control. Cells were harvested 48 hours 
post transfection and checked for transfection efficiency using peGFPN1 transfected wells (data not shown).  293T 
cells did not reveal expression of Lyve-1 in this study regardless of treatment (Ct values over 50).  Points represent 
independent experiments and bars represent the mean of two independent experiments.  
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Transfected 293 cells revealed a significant change in mRNA expression of LEC marker, 
Prox-1, albeit NRT controls also amplified with NRT Ct values varying from between 4 and 12 
cycles from cDNA reactions including RT (Figure 25 and data not shown).  Furthermore, one 
experiment using 293 cells revealed a robust change in Lyve-1 expression suggesting that in 
some circumstances Prox-1 might have the ability to up-regulate mRNA expression levels of 
Lyve-1 (Figure 25).  Real-time results also revealed that cells transfected with plasmid encoding 
Prox-1 consistently expressed LEC markers VEGFR-3 and Lyve-1 (Figures 25 and 26).  This 
lack of LEC marker expression change in response to overexpression of Prox-1 might indicate 
that Prox-1 is at its maximal responsiveness in 293 and 293T cells.  
4.8 RESULTS CONCLUSION 
The above studies outline an attempt to phenotypically characterize 293 and 293T cells 
and attempt to further LEC-likeness through various culture conditions.  Standard and real-time 
RT-PCR revealed that 293 and 293T cells express four of the five LEC markers and that their 
expression levels are similar to that of HDLECs (Figure1-12), revealing that 293 and 293T cells 
have very similar phenotypes to LECs.  Similarly, to investigate protein expression by 293T 
cells, flow cytometry staining was performed for LEC markers, Lyve-1 and PDPN.  Results 
confirmed real-time RT-PCR mRNA expression showing that approximately 99% of 293T cells 
stained positively for PDPN expression and 28% of cells stained positively for Lyve-1 protein 
expression (Figure 15).  An attempt at finding an appropriate culture condition in which 293 and 
293T cells would most resemble LECs was completed using a variety of culture conditions. 
Results from two different 3D models suggest that 293 and 293T cells might not have an 
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influenced phenotype and that they exhibit a more stable LEC-like phenotype (Figures 19-24).  
Furthermore, these analyses reveal that 293 and 293T cells have the potential to serve as model 
LECs due to their phenotypic resemblance. 
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5.0  DISCUSSION 
HEK293 and 293T cells are a typical cell line used widely in the field of research 
primarily for the production of recombinant proteins or investigation into cellular function.  
Though frequently used, the type of cell they are and their phenotypic characterization remains 
incompletely understood.  Despite previous research that suggested 293 cells are neuronal in 
origin, more recent studies have observed expression of a LEC marker, suggesting a need for 
deeper analysis.  This study focuses on the phenotypic characterization of 293 and 293T cells in 
the context of LEC marker expression.  In addition to phenotypic analysis, 293 and 293T cells 
were treated through manipulation of culture conditions in an attempt to further differentiate 
them into LECs or to de-differentiate them for the purpose of controlled differentiation further 
into LECs.  The results presented open a variety of avenues for interpretation and discussion in 
regard to what defines the LEC phenotype, whether 293 cells are LEC-like, troubleshooting 
areas of skepticism, and what the implications are for characterization of 293 and 293T cells as 
LECs.  
5.1 DEFINING A LEC PHENOTYPE 
LECs, as previously discussed, make up the lining of the lymphatic vasculature and have 
multiple functions within the lymphatic system.  Until the discovery of LEC markers VEGFR-3, 
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Lyve-1, Prox-1, and PDPN, it was difficult to study the function of LECs.  More recently 
however, it has been observed that from an immunologic perspective they aid in trafficking of 
DCs to the lymph node and express multiple TLRs [19].  Defining LECs however, has become a 
difficult process that relies heavily upon expression of multiple cellular markers, which in turn, 
contribute to function.  Though there is no strict defining factor, a general understanding is that 
they are a subset of cells that are derived from the cardinal vein to make up the lymphatic system 
and express multiple sub-specific markers to high levels, the most influential being VEGFR-3, 
Lyve-1, Prox-1, PDPN, and CCL21.  Several papers discuss the necessity of Prox-1 expression, 
particularly in early states of differentiation.  In addition, it has been shown that Prox-1 
expression is necessary for the maintenance of the LEC phenotype, as loss of Prox-1 causes 
LECs to phenotypically change into BECs [54].  Secondly, another reference for defining LECs 
comes from the isolation of primary LECs for study in culture.  Typically, LECs are isolated 
using one or multiple cellular markers such as PDPN and Lyve-1.  Similarly, the real-time RT-
PCR data from the findings presented suggest that expression of one or even two LEC markers is 
not unique to many cell lines.  Taken together, this suggests that currently, the best way to 
characterize LECs is by the measurement of the expression levels of multiple LEC markers, 
including VEGFR-3, Lyve-1, PDPN, and Prox-1.   
5.2 CHARACTERIZING 293 AND 293T CELL PHENOTYPE 
The need to explore the phenotype of 293 and 293T cells became apparent when we first 
found expression of the LEC marker, PDPN by 293 cells (Berendam, unpublished data) [36].  As 
already discussed, I found that expression of one LEC marker was not sufficient enough to 
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characterize cells as LEC-like.  This study reveals the expression of multiple LEC markers by 
293 and 293T cells, which strongly suggests we need to re-characterize 293 and 293T cells as 
LEC-like.  Here, real-time RT-PCR analysis revealed that 293 and 293T cells express VEGFR-3, 
Prox-1, PDPN, and Lyve-1.  This expression of multiple LEC markers, though it might not be 
unique given that two other cell lines express four LEC markers, is strongly indicative of LEC-
likeness due to the high levels of expression of VEGFR-3, Prox-1, and PDPN, which nearly 
matches the expression levels of the HDLECs, which are bona fide LECs.   
5.2.1 Caco-2 and Thp-1 Reveal LEC Marker Expression 
Due to the expression of several LEC markers, by multiple cell lines, it becomes 
imperative to take into consideration the level of expression.  Out of the 12 cell lines analyzed 
five expressed at least three LEC markers including HDLECs, 293, 293T, Caco-2, and Thp-1.  
LEC marker expression among 293 and 293T cells was challenged when several, otherwise 
defined, cell types also showed expression of LEC markers.  However, like previously stated, the 
level of marker expression is substantially different when comparing Thp-1 and Caco-2 cells to 
HDLECs.  Secondly, overall marker expression of these cells must be compared to HDLECs.  
For instance, Thp-1 cells express CD209, whereas HDLECs do not. This also is true for the 
expression of IL-7 by HDLECs, but not by Thp-1 cells and expression of CCL21 by HDLECs 
and not by Caco-2 cells.  Similar to marker expression is the importance in the level of LEC 
marker expression in deciding that 293 and 293T cells can be re-defined as LEC-like and that 
Thp-1 and Caco-2 cells cannot be re-defined as LEC-like.  Thirdly, the origin of the cells must 
be considered when re-evaluating LEC marker expression.  Caco-2 cells are human colon 
adenocarcinoma cells that are used in research to study intestinal barrier function [55].  It has 
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been observed that Caco-2 cells during normal growth show the presence of sub-populations, 
each exhibiting a different morphology [55].  This suggests that expression of multiple LEC 
markers could be due to a small sub-population of Caco-2 cells and that all cells might not 
consistently express LEC markers. This is in contrast to PDPN protein expression by 293T cells, 
which is consistent throughout the population (Figure 15) [55].  The second cell type expressing 
multiple LEC markers are Thp-1 cells which are monocytic precursor cells used as model 
monocyte-derived macrophages after treatment with phorbol esters [56].  Post differentiation 
they resemble macrophages morphologically and exhibit similar functions to macrophages such 
as phagocytosis [56].  Likewise, LEC marker expression has been observed on normal 
macrophages, antigen stimulated macrophages, and tumor associated macrophages (TAM) [56, 
57].  Furthermore, Lyve-1 staining has been observed on normal macrophages isolated from 
Prox-1 heterozygous animals, LPS stimulated macrophages have shown binding of CLEC-2 to 
PDPN, and VEGFR-3 protein expression has been observed on tumor-associated macrophages 
[53, 57].  Analogously, HDLECs have been shown to express macrophage markers such as 
macrophage mannose receptor, also known as CD206, revealing an overlap of markers between 
the two cell populations [47].  Therefore, LEC marker expression by Thp-1 cells is not indicative 
that this cell line should be redefined as LEC-like – it could rather reveal an overlap of both 
macrophage and LEC marker expression between both cell types.  
5.2.2 Low Lyve-1 Expression is Not Unique Among LECs 
Another caveat to redefining 293 and 293T cells as LEC-like is the comparatively low 
level of Lyve-1 mRNA and protein expression.  Flow cytometry results suggest that only 20-
30% of 293T cells are expressing Lyve-1 protein (Figure 15).  Like 293 and 293T cells, 
 67 
HDLECs also do not express Lyve-1 to a similar level as other LEC markers including VEGFR-
3, Prox-1, and PDPN when compared to GUSB.  However, low Lyve-1 mRNA and protein 
expression is not unique to LECs and has been shown among isolated cells from animals 
developing AIDS [58].  Other research has found that depending on the type of lymphatic vessel, 
deep, superficial, or subcutaneous, expression of Lyve-1 might vary [59].  For example, Lyve-1 
is often found in dermal tissue of the human skin (deep and superficial layers) but can be 
completely absent in subcutaneous vessels [59].   
Previous research reveals a difference in Lyve-1 expression dependent on the level of 
inflammation in the local environment and many studies do not specifically define expression 
level of Lyve-1, but merely the presence as dictating LEC phenotype [28, 58].  These findings 
together suggest that expression of Lyve-1 to any level, in conjunction with expression of other 
LEC markers, contributes to defining a LEC-like phenotype.  
5.2.3 293 and 293T Cells Are Not Definitively Neuronal or Podocyte-like 
Previous studies have identified expression of neuronal proteins by 293 and 293T cells in 
a study of adenovirus transformation.  Their results concluded that neuronal cells were more 
easily transformed by adenovirus, suggesting that HEK293 cells were neuronal in origin [10].  
To determine the impact of neurofilament expression by 293 and 293T cells, 10 other cell lines 
were analyzed for mRNA expression of the neurofilament light subunit (NEFL).  Results 
revealed that 293 and 293T cells were not unique in their expression of NEFL mRNA (Figure 
12).  Three of the 10 cell lines expressed NEFL to a similar degree as 293 and 293T cells 
including, A549, 786-O, and HDLECs.  The significance of NEFL expression by other cell lines 
suggests that NEFL expression is not restricted to neuronal cells.  Furthermore, the expression of 
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NEFL by HDLECs, suggests that NEFL is widely expressed by cultured cells.  Interestingly, 
studies have shown that Prox-1 can be found in the nuclei of neuroblastomas, suggesting there 
might be a link between LEC marker expression, particularly Prox-1, and neuronal marker 
expression [60].   
To determine resemblance to podocytes 293 and 293T cells were also investigated for 
expression of podocyte markers WT1 and Synpo [43].  Podocytes are typical human kidney cells 
that also express the LEC marker PDPN [61].  Real-time RT-PCR analysis revealed that WT1 
and Synpo expression by 293 and 293T cells was not unique and that many other cell lines 
expressed mRNAs for WT1 and Synpo (Figure 12).  Similar to neurofilament expression, 
podocyte marker expression is not specific enough to define cultured cells, including 293 and 
293T cells, as podocytes.  
The expression of neuronal and podocyte marker mRNA does not define 293 and 293T 
cell phenotype due to similar expression by all of the other cell types.  The expression of NEFL 
by HDLECs, along with previous findings of Prox-1 expression by neuroblastomas, suggests that 
there might be a connection between LEC marker expression and neuronal marker expression. 
Taken together, the expression of NEFL, WT1, and Synpo by 293 and 293T cells is not 
definitive of a neuronal or podocyte-like characterization, leaving the argument that these two 
cell lines are LEC-like intact.   
5.3 FUTURE IMPLICATIONS FOR 293 CELLS AS LEC-LIKE 
The re-characterization of HEK293 and 293T cells as LEC-like brings implications and 
potential to the cell line that was previously unrevealed.  One implication is the need to re-
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evaluate previous research using 293 and 293T cells.  In particular, studies designed using 293 or 
293T cells as a neuronal cell type should be re-evaluated due to the commonality in expression 
of neuronal mRNA by several cell lines.  Similarly, studies using 293 and 293T cells as neuronal 
cells must be re-evaluated due to the ability to redefine 293 and 293T cells as LEC-like.  Along 
with re-evaluation of previous research, this study has revealed the necessity to use one or even 
two markers to define cell type.  This is especially the case for cells like LECs that do not have a 
robust functional method for characterization and must rely heavily upon the expression, in 
particular the level of expression, of multiple known cellular markers.  Lastly, characterization of 
293 and 293T cells as LEC-like provides the potential to use these cells in LEC studies.  As more 
is revealed about the cellular markers expressed and the function of LECs, characterization of 
293 and 293T cells will need to be further evaluated.  Deeper analysis would also reveal 
differences between LECs and 293 cells as well as their potential use, such as investigation into 
the expression and functionality of TLRs by 293 and 293T cells.  Results from experiments such 
as these will continue to determine the degree to which 293 cells can be used as model LECs and 
if they have the potential to become more LEC-like.  
5.4 293 AND 293T CELLS AS MODEL LECS 
One difference between 293 or 293T cells and LECs is their growth in cell culture.  For 
example, 293 and 293T cells have a doubling time between 24 and 35 hours in comparison to 
LECs, which have a doubling time of approximately 2-5 days [62].  Due to this increased 
proliferation and uninhibited growth, 293 and 293T cells might be more suitable for 3D culture.  
One area of study for the lymphatics includes the attempt to form lymphatic vessels in vitro [63].  
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Since 293 and 293T cells phenotypically express many LEC markers and to equal levels, they 
can be re-defined as LEC-like.  Taken together, this provides an opportunity for 293 and 293T 
cells to be used as model LECs in an attempt to form in vitro lymphatic vessels.  Due to 293 and 
293T cell success in 3D culture in this study, a proposed model for forming lymphatic 
vasculature would be with scaffolding modeling lymphatic vasculature formation.  If 293 and 
293T cells formed 3D vasculature it could stand as a model system representing lymphatic 
vasculature response in vivo.  The protein and mRNA expression levels of 293 and 293T cells 
reflect the phenotype of LECs and thus, provide the opportunity to be utilized as model LECs in 
future lymphatic related research, in particular 3D culture to represent in vivo environments.  
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6.0  PUBLIC HEALTH SIGNIFICANCE 
The public health significance of this research is applicable on multiple levels from 
making researchers aware of the need for characterization of previously undetermined cell types 
to describing a new potential for a popularly used cell line.  As previously stated, it is of high 
importance that within the field of basic research, the most accurate system is used to mimic 
human cellular responses. One way in which scientists can ensure accurate results is through the 
use of a characterized cell type that bears significant resemblance to the in vivo cell population.  
This research provides an example of a previously un-determined cell type that is highly used 
and presents convincing data for a new characterization of 293 and 293T cells as LEC-like.  
Similarly, the lymphatics play a crucial role in maintaining fluid balance and can play a key role 
in metastatic spread of cancer through the lymphatic response to VEGF-C [59].  For example, 
lymphedema, a condition in which there is excess fluid in tissues due to malfunction of the 
lymphatic system, is common in women diagnosed and treated for breast cancer [64, 65].  
Furthermore, understanding the role of the lymphatics in metastatic spread is essential in 
uncovering new forms of cancer therapy and treatment.  One of the greatest public health 
advancements within the twentieth century has been the development and implementation of 
vaccines within the community. Recent studies have suggested that LECs play a critical role in 
vaccine response through the trafficking of DCs and T cells to the lymph node and through MHC 
class II antigen presentation [46].  Specific functions and the extent to which LECs play a role in 
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lymphatics are still being investigated.  The identification of an LEC cell line, 293 and 293T 
cells, provides a new avenue through which to further study the role of LECs.  The ease of which 
293 and 293T cells are cultured, and the timeliness of division provides unlimited potential for 
initial studies into understanding the function of LEC markers, interaction with antigen, and 
chemotactic properties.  Continued study into the functional similarity between 293, 293T cells, 
LECs will further reveal their potential as model LECs. 
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